Table 1 Baseline characteristics of patients with and without COPD according to the expert panel and the GOLD definition
All Subjects | Expert Panel | P | GOLD definition | P | |||
|---|---|---|---|---|---|---|---|
(n = 405) | No COPD (n = 158) | COPD (n = 247) | No COPD (n = 161) | COPD (n = 244) | |||
Age, years | 72(69; 77) | 71.5(67; 76) | 73(70; 77) | 0.004 | 72(67; 76) | 73(70; 77) | 0.010 |
Male sex, % | 55.1 | 40.5 | 64.4 | < 0.001 | 34.8 | 68.4 | < 0.001 |
Death, % | 14.9 | 6.3 | 20.5 | < 0.001 | 10.6 | 17.8 | 0.047 |
Pack years smoking | 16.8 (0; 38.8) | 1.5 (0; 23) | 27 (8.3; 51) | < 0.001 | 2.3 (0; 28) | 25.2 (5.5; 51) | < 0.001 |
BMI, kg/m2 | 26.2 (24.1; 28.8) | 27 (24.8; 30.1) | 25.6 (23.4; 28.3) | < 0.001 | 27 (24.7; 30) | 25.6 (23.3; 28.3) | < 0.001 |
Comorbidities and Symptoms | |||||||
Hypertension, % | 39.0 | 42.4 | 36.8 | 0.30 | 46.6 | 34.0 | 0.013 |
Diabetes, % | 8.6 | 8.9 | 8.5 | 1.00 | 9.9 | 7.8 | 0.47 |
Stroke or TIA, % | 22.0 | 17.1 | 25.1 | 0.07 | 18.0 | 24.6 | 0.14 |
Fatigue, % | 41.3 | 46.8 | 37.8 | 0.08 | 46.6 | 37.9 | 0.09 |
Wheezing, % | 63.5 | 55.1 | 68.8 | 0.006 | 59.0 | 66.4 | 0.14 |
COPD Inhalatory Medication | |||||||
Beta2-mimetics, % | 58.2 | 39.9 | 69.9 | < 0.001 | 41.6 | 69.1 | < 0.001 |
Anticholinergics, % | 47.6 | 36.1 | 55.1 | < 0.001 | 36.0 | 55.4 | < 0.001 |
Inhaled Corticosteroids, % | 63.0 | 56.3 | 67.2 | 0.035 | 58.4 | 66.0 | 0.14 |